How to Buy Haemonetics Stock
Haemonetics Corp
Haemonetics is a medical company located in Massachusetts, United States, which is part of the Healthcare sector, and is traded under the ticker HAE on the NYSE exchange.
Haemonetics stock last closed at $63.02, down 1.49% from the previous day, and has decreased 31.46% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.11 percentage points. Haemonetics stock is currently +13.96% from its 52-week low of $55.30, and -35.67% from its 52-week high of $97.97.
There are currently 50.24M HAE shares outstanding. The market value of HAE is $3.17B. In the past 24 hours, 551,755 HAE shares were traded.
How to Buy Haemonetics Stock
Not sure how to invest in Haemonetics stock? Here's how.
- Figure out where to buy Haemonetics stock: You need to pick an online brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you determine where to buy Haemonetics stock.
- Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit money your brokerage account: Choose your payment method and add your details.
- Analyze Haemonetics stock: The Haemonetics ticker symbol is HAE. Is Haemonetics stock a good investment? Should you buy shares of HAE? How do HAE's underlying business fundamentals look? Do top analysts think Haemonetics is a good buy? Why has HAE's stock price moved recently? (Hint: Our stock market analysis website can help you decide if HAE is a good stock to buy).
- Execute your HAE purchase: Decide if you will purchase HAE shares at the current market price or use a limit order to buy HAE stock at a specific price.
- Get the latest news on your investment in HAE: Create a watchlist to watch your investment in Haemonetics stock.
Step 1: Figure out where to buy Haemonetics stock
You need a brokerage account to access the NYSE market and buy HAE shares.
Our favorite brokerage: eToro
We believe that eToro is the best brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global financial markets: From Technology to Industrials, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected the right brokerage, the next step is to fill out some personal information so you can buy HAE stock today.
How to Open a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to open a new trading account.
- Send your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've opened your account on mobile trading apps, you need to deposit funds:
Check out this video walkthrough for more details transferring funds into your new investment account.
Step 4: Analyze Haemonetics stock
After you have figured out the best place to buy Haemonetics stock, it's very important to analyze their stock before you invest, so you actually comprehend the risk and upside.
Haemonetics shares data
Haemonetics Overview
WallStreetZen was built to help everyday investors perform better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on HAE's stock page.
Is HAE stock undervalued?
You can use many financial metrics, analyses, models, and charts to gauge HAE's true value.
Using relative valuations metrics:
- HAE may be undervalued based on its P/E ratio of 24.62x, relative to Medical Instruments & Supplies industry P/E ratio of 40.62x
- HAE may be undervalued based on its P/B ratio of 3.49x, relative to Medical Instruments & Supplies industry P/B ratio of 3.73x
- HAE could be undervalued based on its PEG ratio of 0.56x
You can do more valuation analysis on HAE's stock here.
HAE Financials at a glance
Positive Financial Indicators:
- There are more short-term assets than short-term liabilities on the HAE balance sheet.
- HAE earnings of $180.43M is not enough to cover its interest payments.
Negative Financial Indicators:
- Total HAE debt is higher than 5 years ago, relative to shareholder equity.
- There are more long-term liabilities than short-term assets on the HAE balance sheet.
- HAE profit margin has gone down from 10% to 9.5% in the past year.
- HAE's operating cash flow of $129.25M allows it to safely service it's debt of $1.22B.
- HAE has a relatively high debt to equity ratio of 1.79.
Is HAE stock a Buy, Hold, or Sell, according to analysts?
Out of 5 Wall Street analysts who give forecasts on HAE, the consensus analyst rating on Haemonetics is a Strong Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Haemonetics stock forecast page.
HAE Trading Indicators
How are HAE Revenues/Earnings doing?
Last year, HAE earnings were $130.07M. During the last five year, HAE's earnings have gone up by 10.27% per year. This was slower than the Medical Instruments & Supplies industry average of 24.59%.
Last year, HAE revenue was $1.37B. Over the last five year, HAE's revenue has gone up by 6.57% per year. This was slower than the Medical Instruments & Supplies industry average of 9.67%.
Learn more about HAE's earnings and revenue performance here.
Who is buying/selling HAE?
In the last year, executives and large shareholders at HAE have sold more shares than they have bought.
Roy Galvin, President Global Plasma BC of HAE, was the latest HAE insider to sell. They sold $11,508.28 worth of HAE stock on Nov 1, 2024.
Learn more about who owns HAE stock here.
Does HAE stock generate passive income?
No, Haemonetics doesn't provide an income stream by paying out dividends.
What do other traders have to say about HAE?
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Execute your HAE purchase
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are mostly fine for most investors. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a given dollar amount limit, use a limit order.
Hit the Open Trade button and your broker will place your order.
If you need additional info about investing in stocks on eToro, click the helpful video below:
Step 6: Get the latest news on your investment in HAE
Now that you own some shares in HAE, you'll want to keep up with your new investment.
Start a watchlist to track the latest developments regarding your HAE stock.
HAE Feed
How to Buy Stock in Haemonetics
To reiterate, here are the 6 steps to buy Haemonetics stock:
- Figure out where to buy Haemonetics stock
- Sign up for your brokerage account
- Deposit money your brokerage account
- Analyze Haemonetics stock
- Execute your HAE purchase
- Get the latest news on your investment in HAE
If you need a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to keep an eye on your new investment in Haemonetics, click the button below.
Other Stock Buying Guides You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.